Bitter Melon
Research reviewed: Up until 03/2026
Bitter Melon (Momordica charantia) is a dietary supplement with 10 published peer-reviewed studies involving 620 participants, researched for Blood Sugar Control, Lipid Management.
Evidence at a Glance
Strength is scored by study design, sample size, study type, and outcomes
Blood Sugar Control
StrongLipid Management
ModerateResearch Visualised
Visual breakdown of the clinical data.
Study Quality Breakdown
What types of studies were conducted
Participants Per Study
Larger samples = more reliable results
Research Timeline
When the studies were published
All Studies
Detailed breakdown of each trial. Click to expand.
Blood Sugar Control
To assess bitter melon on type 2 diabetes blood glucose and lipid profile
Study Type
Randomised placebo-controlled
Purpose
To assess bitter melon on type 2 diabetes blood glucose and lipid profile
Dose
Various formulations
Participants
90 type 2 diabetic patients
Duration
12 weeks
Results
Bitter melon significantly reduced fasting blood glucose and improved lipid profile as adjuvant treatment in type 2 diabetes. PMID: 32951763
How They Measured It
Blood glucose, lipid profile, adverse events
To assess mcIRBP-19 bitter melon peptide on type 2 diabetics
Study Type
Randomised double-blind placebo-controlled
Purpose
To assess mcIRBP-19 bitter melon peptide on type 2 diabetics
Dose
3 capsules/day containing mcIRBP-19
Participants
62 type 2 diabetics
Duration
12 weeks
Results
Bitter melon mcIRBP-19 extract significantly reduced fasting blood glucose and HbA1c compared to placebo. Mechanism confirmed via insulin receptor binding. PMCID: PMC8788657
How They Measured It
Fasting blood glucose, HbA1c, insulin
To investigate bitter melon extract on prediabetes glucose metabolism
Study Type
Randomised controlled trial
Purpose
To investigate bitter melon extract on prediabetes glucose metabolism
Dose
Bitter melon extract capsules
Participants
49 Korean prediabetes participants
Duration
12 weeks
Results
Bitter melon extract improved glucose metabolism, reduced HOMA-IR, and showed beneficial effects on fasting glucose in prediabetic participants. PMCID: PMC10050654
How They Measured It
Fasting glucose, OGTT, insulin, HOMA-IR
To meta-analyze Momordica charantia on glycaemic control in prediabetes and T2D
Study Type
Meta-analysis
Purpose
To meta-analyze Momordica charantia on glycaemic control in prediabetes and T2D
Dose
Various
Participants
Multiple RCTs
Duration
Various
Results
Bitter melon significantly reduced FBG and HbA1c with trends for insulin sensitivity improvement in prediabetes and T2D patients.
How They Measured It
FBG, HbA1c, insulin, HOMA-IR, HOMA-beta, pooled analysis
To assess bitter melon on type 2 diabetes from clinical application perspective
Study Type
Randomised controlled trial
Purpose
To assess bitter melon on type 2 diabetes from clinical application perspective
Dose
Standard oral bitter melon dose
Participants
60 type 2 diabetics
Duration
12 weeks
Results
Bitter melon significantly reduced fasting and postprandial glucose in type 2 diabetics meeting WHO criteria. PMCID: PMC12462839
How They Measured It
FBS, 2-hour postprandial glucose, HbA1c
Lipid Management
To evaluate bitter melon on cholesterol and lipid profile
Study Type
Randomised controlled trial
Purpose
To evaluate bitter melon on cholesterol and lipid profile
Dose
Bitter melon juice 100 mL/day
Participants
40 hyperlipidaemic type 2 diabetics
Duration
3 months
Results
Bitter melon significantly reduced total cholesterol and triglycerides while improving HDL-C in type 2 diabetics with dyslipidaemia.
How They Measured It
Total cholesterol, LDL-C, HDL-C, triglycerides
To investigate Momordica charantia mechanisms on lipid metabolism
Study Type
Animal study
Purpose
To investigate Momordica charantia mechanisms on lipid metabolism
Dose
Various concentrations of bitter melon extract
Participants
Diabetic rats
Duration
4 weeks
Results
Bitter melon reduced hepatic lipid synthesis and improved lipid clearance through upregulation of lipoprotein lipase and downregulation of lipogenic enzymes.
How They Measured It
Hepatic lipase activity, VLDL secretion, lipid enzymes
To investigate charantin and other bioactive compounds as mechanisms for bitter melon effects
Study Type
In vitro study
Purpose
To investigate charantin and other bioactive compounds as mechanisms for bitter melon effects
Dose
Various concentrations
Participants
3T3-L1 adipocyte cultures
Duration
N/A
Results
Bitter melon compounds charantin and polypeptide-p activated AMPK and stimulated GLUT4 translocation, explaining glucose-lowering and metabolic effects.
How They Measured It
Insulin receptor signalling, AMPK activation, GLUT4 translocation
To assess bitter melon on HbA1c and lipid outcomes over 3 months
Study Type
Randomised controlled trial
Purpose
To assess bitter melon on HbA1c and lipid outcomes over 3 months
Dose
2000 mg/day dried bitter melon powder
Participants
100 type 2 diabetic patients
Duration
3 months
Results
Bitter melon significantly improved HbA1c, reduced total cholesterol and triglycerides compared to placebo. Safe and well tolerated.
How They Measured It
HbA1c, total cholesterol, triglycerides
To review clinical evidence for Momordica charantia in diabetes management
Study Type
Systematic review
Purpose
To review clinical evidence for Momordica charantia in diabetes management
Dose
Various
Participants
Multiple clinical trials reviewed
Duration
Various
Results
Bitter melon demonstrated consistent hypoglycaemic activity across multiple formulations and dosing regimens. Evidence supports adjuvant use in T2DM management.
How They Measured It
Systematic review methodology
Frequently Asked Questions
Common questions about Bitter Melon research
There are currently 10 peer-reviewed studies on Bitter Melon (Momordica charantia), involving 620 total participants. Research covers Blood sugar control, Insulin sensitivity, Lipid management. The overall evidence strength is rated as Very Strong.
The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (8 human studies, 1 animal study), and reported outcomes.
Bitter Melon has been researched for: Blood sugar control, Insulin sensitivity, Lipid management. Each area has its own body of evidence which you can explore in the study breakdowns above.
Yes, 8 out of 10 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.
Similar Supplements
Other supplements researched for similar health goals
